The current ICCC market cap is 38.99M. The company's latest EPS is USD -0.7451 and P/E is -6.75.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.8M | 3.91M | 3.45M | 3.53M | 5.4M |
Operating Income | -838k | -1.63M | -2.26M | -1.3M | -1.18M |
Net Income | -878k | -1.67M | -2.32M | -1.38M | -940k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 13.72M | 15.34M | 19.24M | 18.57M | 17.47M |
Operating Income | -954k | -1.38M | 257k | -2.3M | -5.75M |
Net Income | -1.3M | -1.02M | -78k | -2.49M | -5.78M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 46.4M | 44.86M | 43.12M | 44.01M | 44.55M |
Total Liabilities | 14.42M | 14.48M | 14.96M | 17.15M | 18.53M |
Total Equity | 31.98M | 30.38M | 28.16M | 26.86M | 26.01M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 38.69M | 40.35M | 44.47M | 44.86M | 43.81M |
Total Liabilities | 9.7M | 12.08M | 11.89M | 14.48M | 18.82M |
Total Equity | 28.99M | 28.27M | 32.58M | 30.38M | 24.99M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -246k | -1.54M | -2.76M | -3.44M | -3.95M |
Investing | -2.47M | -3.96M | -682k | -1.39M | -1.92M |
Financing | 1.36M | 1.12M | 748k | 496k | 2.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 234k | 1.32M | 954k | -1.54M | -4.67M |
Investing | -3.4M | -2.57M | -1.6M | -3.96M | -1.89M |
Financing | 6.94M | 1.91M | 3.88M | 1.12M | 1.75M |
Market Cap | 38.99M |
Price to Earnings Ratio | -6.75 |
Price to Sales Ratio | 2.23 |
Price to Cash Ratio | 39.83 |
Price to Book Ratio | 1.56 |
Dividend Yield | - |
Shares Outstanding | 7.75M |
Average Volume (1 week) | 6.97k |
Average Volume (1 Month) | 8.55k |
52 Week Change | 2.03% |
52 Week High | 6.05 |
52 Week Low | 4.26 |
Spread (Intraday) | 0.2 (3.84%) |
Company Name | ImmuCell Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.immucell.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.